KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,116 | +114.6% | 18,426 | +175.2% | 0.15% | +131.7% |
| Q2 2023 | $1,452 | -52.2% | 6,696 | -60.0% | 0.06% | -55.9% |
| Q1 2023 | $3,038 | +74.6% | 16,726 | +88.9% | 0.14% | +49.0% |
| Q4 2022 | $1,740 | -99.9% | 8,855 | +11.3% | 0.10% | -11.1% |
| Q3 2022 | $1,789,000 | +560.1% | 7,955 | +271.6% | 0.11% | +440.0% |
| Q2 2022 | $271,000 | 0.0% | 2,141 | 0.0% | 0.02% | +11.1% |
| Q1 2022 | $271,000 | – | 2,141 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |